✦ LIBER ✦

PHP138 Intangible Capital and Return on Assets in the Pharmaceutical Industry

✍ Scribed by J. Mahlich; B. Yurtoglu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intangible capital in the pharmaceutical

✍ Katherine I. Gleason; Mark Klock 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 180 KB

The return on R&D versus capital expendi

✍ Ping-Hung Hsieh; Mishra, C.S.; Gobeli, D.H. 📂 Article 📅 2003 🏛 IEEE 🌐 English ⚖ 532 KB

Measuring and valuing intangible capital

✍ Mark Klock; Pamela Megna 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Putting a new spin on R&D assets in the

✍ Janet M. Dewdney; Richard A.G. Smith 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Impact of Intangible Capital on Producti

✍ SUPRIYO DE; DILIP DUTTA 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

PHP63 Potential Effects of Changes in Pr

✍ S.A. Memis; C. Deger; B. Marmarali; E. Parali; F. Sumer; K. Karakeben; M. Kayadi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB